ReviewJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners2018

BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.

Sandra Cuellar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.